Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Endocrinol.

Sec. Cancer Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1616661

This article is part of the Research TopicAltered Metabolic Traits in Gastrointestinal Tract Cancers, volume IIView all 5 articles

Tumor Microenvironment and Metabolic Reprogramming: Unraveling the Complex Interplay in Gastrointestinal Tumor Liver Metastasis

Provisionally accepted
  • 1Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, China
  • 2Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China

The final, formatted version of the article will be published soon.

Gastrointestinal tumors (GITs) are among the most prevalent and lethal malignancies worldwide, with liver metastasis (LM) being a major contributor to poor patient prognosis, contributing to recurrence in a substantial proportion (approximately 37%) of patients undergoing radical gastrectomy. Dismally, the prognosis for GI-LM (Gastrointestinal tumors Liver Metastasis) patients remains exceedingly poor, with survival rates beyond five years languishing below 10%. Recent studies have highlighted the critical role of tumor metabolic reprogramming and its interaction with the tumor microenvironment (TME) in the progression of gastrointestinal tumor liver metastasis. Tumor cells undergo metabolic alterations, such as enhanced glycolysis, increased glutamine metabolism, and altered lipid metabolism, to meet the demands of rapid proliferation. These metabolic changes also reshape the liver microenvironment by secreting metabolites (e.g., lactate, succinate), promoting immune suppression, angiogenesis, and stromal remodeling, thereby facilitating liver metastasis. Conversely, the liver microenvironment, including immune cells, stromal cells, and extracellular matrix components, influences tumor cell metabolism through nutrient competition, cytokine signaling, and hypoxia-driven mechanisms, creating a bidirectional interaction. This review summarizes the molecular mechanisms underlying the interplay between tumor metabolic reprogramming and the microenvironment in gastrointestinal tumor liver metastasis, explores how metabolic changes drive TME remodeling to promote metastasis, and discusses emerging therapeutic strategies targeting these mechanisms. The aim is to provide new insights for precision medicine in treating gastrointestinal tumor liver metastasis.

Keywords: Gastrointestinal tumors, liver metastasis, tumor metabolism, Tumor Microenvironment, metabolic reprogramming, Immune Evasion, Stromal interactions

Received: 23 Apr 2025; Accepted: 30 Jul 2025.

Copyright: © 2025 Wang, Ma, Lv, Yu, Liu and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Shanglong Liu, Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, China
Yun Lu, Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.